State Street Corporation »

Inhibikase Therapeutics shares owned by State Street Corporation

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by State Street Corporation from 13F filings

Historical chart of State Street Corporation investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by State Street Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $13k 10k 1.31
2024-03-31 $22k 10k 2.16
2023-12-31 $13k 10k 1.27
2023-09-30 $14k 10k 1.41
2023-06-30 $35k 10k 3.48